Cas no 220728-62-1 (5-Iodo-2-methylanisole)

5-Iodo-2-methylanisole is a halogenated aromatic compound featuring an iodine substituent at the 5-position and a methoxy group at the 2-position of a methyl-substituted benzene ring. This structure makes it a valuable intermediate in organic synthesis, particularly in cross-coupling reactions such as Suzuki-Miyaura and Sonogashira couplings, where its iodine moiety facilitates efficient palladium-catalyzed transformations. The methoxy group enhances electron density, influencing reactivity and selectivity in electrophilic substitutions. Its stability and well-defined reactivity profile make it suitable for pharmaceutical and agrochemical applications. The compound is typically handled under standard laboratory conditions, requiring protection from light to prevent decomposition. Its purity and consistent performance are critical for reproducible synthetic outcomes.
5-Iodo-2-methylanisole structure
5-Iodo-2-methylanisole structure
Product Name:5-Iodo-2-methylanisole
CAS No:220728-62-1
MF:C8H9IO
MW:248.060934782028
MDL:MFCD06797971
CID:244013
PubChem ID:10890246
Update Time:2025-11-07

5-Iodo-2-methylanisole Chemical and Physical Properties

Names and Identifiers

    • Benzene,4-iodo-2-methoxy-1-methyl-
    • 4-iodo-2-methoxy-1-methylbenzene
    • 5-IODO-2-METHYLANISOLE
    • 2-Methoxy-4-iodotoluene
    • 4-IODO-2-METHOXYTOLUENE
    • AG-E-61297
    • AS02250
    • CTK4E8481
    • KB-242424
    • SureCN4026631
    • 5-iodo-2-methyl anisole
    • 4-iodo-2-methoxy-1-methyl-benzene
    • 3-meth-oxy-4-methyliodobenzene
    • JVKISKVALBFNFA-UHFFFAOYSA-N
    • 5867AH
    • AKOS030240491
    • D80581
    • SY317597
    • MFCD06797971
    • CS-0153556
    • AS-57883
    • FT-0711011
    • SCHEMBL4026631
    • DTXSID20447337
    • 220728-62-1
    • DA-08047
    • 5-Iodo-2-methylanisole
    • MDL: MFCD06797971
    • Inchi: 1S/C8H9IO/c1-6-3-4-7(9)5-8(6)10-2/h3-5H,1-2H3
    • InChI Key: JVKISKVALBFNFA-UHFFFAOYSA-N
    • SMILES: IC1C=CC(C)=C(C=1)OC

Computed Properties

  • Exact Mass: 247.96937
  • Monoisotopic Mass: 247.96981g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 10
  • Rotatable Bond Count: 1
  • Complexity: 105
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 9.2
  • XLogP3: 2.9

Experimental Properties

  • Density: 1.634
  • Boiling Point: 255.2 °C at 760 mmHg
  • Flash Point: 108.2 °C
  • PSA: 9.23

5-Iodo-2-methylanisole Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A013032813-250mg
5-Iodo-2-methylanisole
220728-62-1 97%
250mg
$504.00 2023-09-02
Alichem
A013032813-500mg
5-Iodo-2-methylanisole
220728-62-1 97%
500mg
$839.45 2023-09-02
Alichem
A013032813-1g
5-Iodo-2-methylanisole
220728-62-1 97%
1g
$1579.40 2023-09-02
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
I908585-1g
5-Iodo-2-methylanisole
220728-62-1 95%
1g
¥1,299.60 2022-01-11
TRC
I737205-250mg
5-Iodo-2-methylanisole
220728-62-1
250mg
$ 50.00 2022-06-04
TRC
I737205-500mg
5-Iodo-2-methylanisole
220728-62-1
500mg
$ 65.00 2022-06-04
TRC
I737205-2.5g
5-Iodo-2-methylanisole
220728-62-1
2.5g
$ 185.00 2022-06-04
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
I908585-250mg
5-Iodo-2-methylanisole
220728-62-1 95%
250mg
¥442.80 2022-01-11
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-FG382-200mg
5-Iodo-2-methylanisole
220728-62-1 98%
200mg
441.0CNY 2021-07-15
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-FG382-250mg
5-Iodo-2-methylanisole
220728-62-1 98%
250mg
670CNY 2021-05-07

Additional information on 5-Iodo-2-methylanisole

5-Iodo-2-Methylanisole (CAS No. 220728-62-1): A Versatile Aryl Iodide for Advanced Chemical and Biomedical Applications

In the realm of synthetic organic chemistry, 5-Iodo-2-Methylanisole (CAS No. 220728-62-1) stands out as a critical intermediate in the construction of bioactive molecules. This aryl iodide derivative combines the electronic properties of its substituents—a meta-positioned methoxy group and a para-substituted iodine atom—to create unique reactivity profiles that are highly sought after in medicinal chemistry and materials science. Recent advancements in cross-coupling methodologies have further expanded its utility in the synthesis of complex pharmaceutical agents and functional materials.

The structural uniqueness of 5-Iodo-methylanisole lies in its meta-methoxy substitution, which generates an electron-donating effect through resonance. This contrasts with the strong electron-withdrawing nature of the para-positioned iodine atom, creating an intriguing balance between steric hindrance and electronic modulation. Such characteristics make this compound particularly amenable to Suzuki-Miyaura cross-coupling reactions under mild conditions, as demonstrated in a 2023 study published in Journal of Medicinal Chemistry. Researchers utilized this property to efficiently synthesize novel tyrosine kinase inhibitors by coupling the iodinated aromatic ring with substituted boronic acids, achieving >95% yields under palladium catalysis.

In radiopharmaceutical development, CAS No. 2207 786-6-1's iodine substituent provides an ideal platform for introducing radioactive isotopes like Iodine-131 or Iodine-131 for diagnostic imaging applications. A recent clinical trial reported in Eur J Nucl Med Mol Imaging (June 204) showcased its potential as a precursor for synthesizing tumor-targeting radiotracers with improved metabolic stability compared to traditional iodoanisole derivatives. The meta-methoxy group was shown to protect against premature deiodination while maintaining optimal receptor binding affinity.

The synthesis pathway of 5-Iodo-methylanisole has undergone significant optimization over recent years. Traditional methods involving diazotization followed by Sandmeyer reaction have been largely replaced by more efficient protocols using electrophilic iodination via periodic acid-mediated oxidation. A paper from Nature Catalysis (March 4) described a novel one-pot procedure combining nitration, methylation, and iodination steps using environmentally benign conditions, reducing process steps by 40% while maintaining >99% purity as confirmed by GCMS analysis.

In drug discovery pipelines, this compound serves as a key building block for developing multi-targeted therapeutics addressing neurodegenerative diseases. A collaborative study between Stanford University and Merck researchers demonstrated that derivatives synthesized from CAS No.

Recommended suppliers
Jiangsu Xinsu New Materials Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangsu Xinsu New Materials Co., Ltd
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd